Introduction to Tat Ka Wai Hong Pharmaceutical Group
Tat Ka Wai Hong Pharmaceutical Group, a modern pharmaceutical company, achieves comprehensive and harmonious development across various sectors, including R&D, manufacturing, marketing, pharmaceutical circulation, retail chain pharmacies (DTP professional pharmacies), and assisted reproductive technology services.
Pharmaceutical R&D
The company focuses on the research and development of innovative traditional Chinese medicine drugs, chemical innovative drugs, and Health products. The company has formed a team with extensive experience in new drug development. With their efforts, multiple new drugs have entered the clinical research stage.
Hunan Tat Ka Wai Hong Regenerative Medicine Research Institute Co., Ltd., a branch of the company, focuses on researching and developing internationally leading cell medicine research technologies, cell storage technologies, cell quality detection technologies, and cell transplantation treatments. It aims at the research and development of innovative technologies and new pharmaceutical products in stem cells and strives to build an innovative platform for regenerative medicine that integrates research and development, achievement transformation, industrial incubation, and technical services.
Pharmaceutical Industry
The goup owns two pharmaceutical companies,Tat Ka Wai Hong Biopharmaceutical Co., Ltd. (Hunan Province Intelligent Manufacturing Benchmark Workshop) and Hunan Tianji Caotang Pharmaceutical Co., Ltd. (Provincial Enterprise Technology Center), which in total own 9 production lines covering traditional Chinese medicine extraction, tablets, capsules, granules, pills, oral liquids, alcoholic beverages, topical solutions, and medical protective equipment. The group hold Drug Registration Approval Forms of over 100 types.
Medical circulation
Tat Ka Wai Hong mainly engages in retail and pharmaceutical logistics (including cold chain logistics) services of various medicines, medical equipment, and health products and features in selling anti-tumour, transplantation and respiratory medication. The group sets new and special drugs as the main business direction.Tat Ka Wai Hong owns a 50000 square meters intelligent logistics center, which adopts the world’s leading intelligent equipment and systems and can quickly respond to orders from all over the country and even abroad. It is one of the key pharmaceutical reserve enterprises and public health emergency material storage enterprises in Hunan Province.
Pharmaceutical Retail
In 2002, Tat Ka Wai Hong established the first special outpatient service pharmacy in Hunan Province. It has won the honor of “Top Ten DTP Pharmacy” for many years with the unique “chronic disease management+professional service”. Relying on the advantage in incorporated wholesale and retail services and a mature professional pharmacy service model, Tat Ka Wai Hong has expanded its professional pharmacies to Hainan, Ningxia, Shanxi, Beijing, Anhui, Hebei and so on and owns nearly 2000 chain pharmacies and more than 20000 types of drugs.
Medical Service
Changsha Jiachen Reproductive and Genetic Hospital is a tertiary specialized hospital that possesses strong medical resources. It collaborates with Grade A tertiary general hospitals in Hunan province in the form of an integrated healthcare association. The hospital is keen on forming an integrated hospital of traditional Chinese and Western medicine that offers diversified health services, including gynecology, immune preservation, traditional Chinese medicine adjustments, medical aesthetics, preventive healthcare, and integrated medical care, and features immunization for fetal protection and stem cell intervention for clinical treatment.
Tat Ka Wai Hong adheres to the core values of “medicine is Tat Ka,Wai Hong is the world”, adheres to the business philosophy of “quality first, integrity-based”, establish the first professional pharmacy in China, provides a good life and health services for the public, and constructs a new coordinate for integrated innovation and industrial upgrading in the era of Healthy China strategy!